Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
300.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.60 (0.199%)
Market Cap: £1.04b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

1 Sep 2017 12:42

RNS Number : 6105P
Breedon Group PLC
01 September 2017
 

 

 

1 September 2017

 

BREEDON GROUP plc

("Breedon" or the "Company")

 

Director and PDMR Dealings

 

The Company has been notified that Alan Mackenzie, Chief Executive of Breedon Northern Limited and a Person Discharging Managerial Responsibilities ('PDMR'), has sold 15,300 ordinary shares in the Company ('Ordinary Shares') at a price of 89.5p per Ordinary Share.

 

As at today there are 1,446,562,770 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

- ends -

 

Enquiries:

 

Breedon Group plc

Pat Ward, Group Chief Executive 01332 694010

Stephen Jacobs, Head of Communications 07831 764592

 

Cenkos Securities plc (NOMAD and Joint Broker)

Max Hartley 020 7397 8900

 

Numis Securities (Joint Broker)

Heraclis Economides

Ben Stoop 020 7260 1000

 

More about Breedon Group

 

Breedon Group plc is the UK's largest independent construction materials group. It operates the country's largest cement plant, two cementitious import terminals, around 60 quarries, 30 asphalt plants, 200 ready-mixed concrete plants and three concrete products plants nationwide. The Group employs around 2,300 people and has more than 750 million tonnes of mineral reserves and resources. Its strategy is to continue growing organically and through acquisition of businesses in the UK heavyside construction materials market.

Notification and public disclosure of transactions by persons discharging managerial

responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alan Mackenzie

2

Reason for the notification

a)

Position/status

Chief Executive - Breedon Northern (PDMR)

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800ZQKCIVCPN9H229

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of no par value

 

JE00B2419D89

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

89.5p per share

15,300

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

 

 

15,300

 

89.5p per share

e)

Date of transaction

31 August 2017

f)

Place of the transaction

London Stock Exchange (AIM)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSFFFFFWSELU
Date   Source Headline
10th Jul 20197:00 amRNSHolding(s) in Company
9th Jul 20192:57 pmRNSHolding(s) in Company
7th Jun 20194:44 pmRNSHolding(s) in Company
7th Jun 20199:00 amRNSHolding(s) in Company
4th Jun 20191:01 pmRNSDirector / PDMR Dealings & Total Voting Rights
29th May 201912:38 pmRNSFurther re: Intended Sale of Shares
29th May 20197:05 amRNSIntended Sale of Shares
29th May 20197:00 amRNSDirectorate Change
7th May 20195:05 pmRNSDirector / PDMR Dealings & Total Voting Rights
30th Apr 20192:39 pmRNSResult of AGM
30th Apr 20197:00 amRNSAGM Statement
16th Apr 201910:14 amRNSDirectors' and PDMRs' Dealings
8th Apr 20193:12 pmRNSDirector and PDMR Dealings & Issue of Equity
2nd Apr 201912:02 pmRNSDirector and PDMR Dealings and Issue of Equity
1st Apr 20195:00 pmRNSGrant of SAYE Options and PDMR Dealings
18th Mar 20199:23 amRNSDirector Dealings
6th Mar 20197:00 amRNSAnnual Results 2018
15th Feb 201910:53 amRNSHolding(s) in Company
23rd Jan 20192:30 pmRNSBlock listing Interim Review
18th Dec 201811:20 amRNSDirectorate Change
17th Dec 201810:20 amRNSDirector/PDMR Shareholding
14th Dec 20183:46 pmRNSDirector/PDMR Shareholding
12th Dec 20182:27 pmRNSDirector/PDMR Shareholding
7th Dec 20181:00 pmRNSDirector/PDMR Shareholding
6th Dec 20184:57 pmRNSDirector/PDMR Shareholding
27th Nov 201812:00 pmRNSTotal Voting Rights
21st Nov 20187:00 amRNSTrading Update
23rd Oct 20183:55 pmRNSDirector/PDMR Shareholding
17th Oct 20184:42 pmRNSDirector/PDMR Shareholding
16th Oct 20185:00 pmRNSGrant of SAYE Options and PDMR Dealings
12th Oct 201810:00 amRNSDirector/PDMR Shareholding
1st Oct 20188:05 amRNSAppointment of Non-Executive Director
25th Sep 20184:17 pmRNSDirector/PDMR Shareholding
14th Sep 20183:21 pmRNSHolding(s) in Company
14th Sep 20183:20 pmRNSHolding(s) in Company
5th Sep 20187:01 amRNSAppointment of Non-Executive Director
5th Sep 20187:00 amRNSHalf-year Report
1st Aug 20183:57 pmRNSHolding(s) in Company
25th Jul 20182:58 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSBlock Listing Update
2nd Jul 20187:00 amRNSBREEDON COMPLETES ASSET SWAP WITH TARMAC
1st Jun 20185:30 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSAcquisition of Blinkbonny Quarry
17th May 20184:55 pmRNSGrant of SAYE Options and PDMR Dealings
11th May 20183:30 pmRNSResults of Open Offer
8th May 201812:49 pmRNSDirector and PDMR Dealings
30th Apr 20184:19 pmRNSDirector/PDMR Shareholding
27th Apr 20182:18 pmRNSAdditional Block Listing of Ordinary Shares
26th Apr 20181:29 pmRNSDirector and PDMR Dealings and Issue of Equity
26th Apr 20188:00 amRNSCMA's Review of Proposed Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.